GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Kuangli Bio-Tech Holdings Co Ltd (TPE:6431) » Definitions » Cash And Cash Equivalents

Kuangli Bio-Tech Holdings Co (TPE:6431) Cash And Cash Equivalents : NT$332.0 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Kuangli Bio-Tech Holdings Co Cash And Cash Equivalents?

Kuangli Bio-Tech Holdings Co's quarterly cash and cash equivalents declined from Sep. 2024 (NT$78.67 Mil) to Dec. 2024 (NT$41.59 Mil) but then increased from Dec. 2024 (NT$41.59 Mil) to Mar. 2025 (NT$331.98 Mil).

Kuangli Bio-Tech Holdings Co's annual cash and cash equivalents declined from Dec. 2022 (NT$141.89 Mil) to Dec. 2023 (NT$63.22 Mil) and declined from Dec. 2023 (NT$63.22 Mil) to Dec. 2024 (NT$41.59 Mil).


Kuangli Bio-Tech Holdings Co Cash And Cash Equivalents Historical Data

The historical data trend for Kuangli Bio-Tech Holdings Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuangli Bio-Tech Holdings Co Cash And Cash Equivalents Chart

Kuangli Bio-Tech Holdings Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114.44 162.17 141.89 63.22 41.59

Kuangli Bio-Tech Holdings Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.34 104.39 78.67 41.59 331.98

Kuangli Bio-Tech Holdings Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Kuangli Bio-Tech Holdings Co  (TPE:6431) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Kuangli Bio-Tech Holdings Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Kuangli Bio-Tech Holdings Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Kuangli Bio-Tech Holdings Co Business Description

Traded in Other Exchanges
N/A
Address
Jianguo North Road, 9th Floor, No. 66, Section. 2, Zhongshan District, Taipei, TWN, 10485
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.

Kuangli Bio-Tech Holdings Co Headlines

No Headlines